作者
Mahesh V Madhavan, Ajay J Kirtane, Björn Redfors, Philippe Généreux, Ori Ben-Yehuda, Tullio Palmerini, Umberto Benedetto, Giuseppe Biondi-Zoccai, Pieter C Smits, Clemens von Birgelen, Roxana Mehran, Thomas McAndrew, Patrick W Serruys, Martin B Leon, Stuart J Pocock, Gregg W Stone
发表日期
2020/2/18
期刊
Journal of the American College of Cardiology
卷号
75
期号
6
页码范围
590-604
出版商
American College of Cardiology Foundation
简介
Background
The majority of stent-related major adverse cardiovascular events (MACE) after percutaneous coronary intervention (PCI) are believed to occur within the first year. Very-late (>1-year) stent-related MACE have not been well described.
Objectives
The purpose of this study was to assess the frequency and predictors of very-late stent-related events or MACE by stent type.
Methods
Individual patient data from 19 prospective, randomized metallic stent trials maintained at a leading academic research organization were pooled. Very-late MACE (a composite of cardiac death, myocardial infarction [MI], or ischemia-driven target lesion revascularization [ID-TLR]), and target lesion failure (cardiac death, target-vessel MI, or ID-TLR) were assessed within year 1 and between 1 and 5 years after PCI with bare-metal stents (BMS), first-generation drug-eluting stents (DES1) and second-generation drug-eluting …
学术搜索中的文章
MV Madhavan, AJ Kirtane, B Redfors, P Généreux… - Journal of the American College of Cardiology, 2020